Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...
The case explains the statutory framework governing appeals and revisions under the Income-tax Act. It highlights the role of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results